Generic competition · all medicines · read 12 November 2026
Is there a generic of Furosemide, and who makes it?
Furosemide appears in 4 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 20 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came between 3.4 and 3.5 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Furosemide appears in 4 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 20 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Where both are dated, the first generic approval came between 3.4 and 3.5 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Tablet, Oral
Four or more generic makers listed
Brand listed as marketed: Furosemide. 6 generic makers with 16 generic products listed as marketed; the first generic approval is dated 26 September 1985.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Hikma Pharmaceuticals Usa Inc | 24 January 1986 | 1 |
| Prinston Pharmaceutical Inc | 26 March 2004 | 3 |
| Leading Pharma Llc | 9 November 2005 | 3 |
| Ipca Laboratories Ltd | 18 September 2006 | 3 |
| Graviti Pharmaceuticals Private Ltd | 17 October 2022 | 3 |
| Aurobindo Pharma Ltd | 17 July 2025 | 3 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Injectable, Injection
Four or more generic makers listed
Brand listed as marketed: Furosemide. 14 generic makers with 14 generic products listed as marketed; the first generic approval is dated 9 September 1985.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Accord Healthcare Inc | 15 December 1986 | 1 |
| Hospira Inc | 28 May 1999 | 1 |
| Apotex Inc | 22 March 2007 | 1 |
| Baxter Healthcare Corp | 27 January 2014 | 1 |
| Avet Lifesciences Ltd | 26 August 2014 | 1 |
| Eugia Pharma Specialities Ltd | 3 May 2019 | 1 |
| Gland Pharma Ltd | 1 July 2020 | 1 |
| Areva Pharmaceuticals Inc | 18 December 2020 | 1 |
| Sagent Pharmaceuticals | 27 January 2021 | 1 |
| Meitheal Pharmaceuticals Inc | 27 January 2022 | 1 |
| Mankind Pharma Ltd | 16 December 2022 | 1 |
| Saba Ilac Sanayive Ticaret As | 2 April 2024 | 1 |
2 more makers are listed in the data.
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution, Oral
One to three generic makers listed
Every brand product here is listed as discontinued. 1 generic maker with 2 generic products listed as marketed; the first generic approval is dated 22 April 1987.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Hikma Pharmaceuticals Usa Inc | 22 April 1987 | 2 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution, Subcutaneous
Brand listed, no generic listed as marketed
Brand listed as marketed: Furoscix, Furoscix Readyflow (Autoinjector) and Lasix Onyu. No generic is listed as marketed.
Patents and exclusivities still listed
- 3 April 2034Patent 11433044
- 3 April 2034Patent 9884039
- 3 April 2034Patent 12370168 drug product
- 3 April 2034Patent 10272064 drug product
- 3 January 2040Patent 11246851 drug product
- 3 January 2040Patent 12318363 drug product
- 30 January 2040Patent 12491197 drug product
- 30 January 2040Patent 12491196 drug product
9 more patents are listed.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.